Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo
- PMID: 11478679
- DOI: 10.1099/0022-1317-50-8-743
Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo
Abstract
Distinct isoforms of secreted aspartyl proteinases (Sap) of Candida albicans are important virulence factors for different types of candidosis. Predominant expression of Sap1-3 has been shown to be crucial for superficial infections in experimental mucosal and cutaneous candidosis, whereas Sap4-6 might be important for systemic disease. This in-vivo study investigated Sap expression in two samples from patients with oral candidosis and from cutaneous infection. Two different polyclonal antibodies directed against Sap1-3 and Sap4-6 were used for ultrastructural characterisation of protein localisation and expression. Post-embedding immuno-electron microscopy revealed Sap1-3 and Sap4-6 immunoreactivity in all samples. All C. albicans cells expressed predominantly the proteinases Sap1-3 which were evenly distributed within the cell wall and cytoplasmic membrane. In contrast, Sap4-6 labelling was only evident in a few fungal cells. In particular it was localised at the tips of hyphal cells during invasion. These data suggest a different pathogenetic role for Sap1-3 and Sap4-6 during host-fungal interaction.
Similar articles
-
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis.Mol Microbiol. 1999 Oct;34(1):169-80. doi: 10.1046/j.1365-2958.1999.01590.x. Mol Microbiol. 1999. PMID: 10540295
-
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity.Mol Microbiol. 1998 Jul;29(2):605-15. doi: 10.1046/j.1365-2958.1998.00957.x. Mol Microbiol. 1998. PMID: 9720876
-
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients.J Invest Dermatol. 1999 Mar;112(3):383-6. doi: 10.1046/j.1523-1747.1999.00525.x. J Invest Dermatol. 1999. PMID: 10084319
-
[What functions do six different genes for secretory proteinases have in Candida albicans?].Mycoses. 1998;41 Suppl 1:47-50. doi: 10.1111/j.1439-0507.1998.tb00583.x. Mycoses. 1998. PMID: 9717386 Review. German.
-
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents. doi: 10.1128/MMBR.67.3.400-428.2003. Microbiol Mol Biol Rev. 2003. PMID: 12966142 Free PMC article. Review.
Cited by
-
Promising immunotherapeutic _targets for treating candidiasis.Front Cell Infect Microbiol. 2024 Feb 9;14:1339501. doi: 10.3389/fcimb.2024.1339501. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38404288 Free PMC article. Review.
-
Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women.Mycopathologia. 2004 Apr;157(3):255-61. doi: 10.1023/b:myco.0000024173.02010.a5. Mycopathologia. 2004. PMID: 15180151
-
Distribution of secreted aspartyl proteinases using a polymerase chain reaction assay with SAP specific primers in Candida albicans isolates.Folia Microbiol (Praha). 2005;50(5):409-13. doi: 10.1007/BF02931422. Folia Microbiol (Praha). 2005. PMID: 16475500
-
A review of the ultrastructural features of superficial candidiasis.Mycopathologia. 2011 Apr;171(4):235-50. doi: 10.1007/s11046-010-9373-7. Epub 2010 Oct 22. Mycopathologia. 2011. PMID: 20967501 Review.
-
Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing.Antimicrob Agents Chemother. 2015 Apr;59(4):2153-68. doi: 10.1128/AAC.03599-14. Epub 2015 Feb 2. Antimicrob Agents Chemother. 2015. PMID: 25645848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
